Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes

PURPOSE:The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP). METHODS:Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to id...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cornea 2010-03, Vol.29 (3), p.254-259
Hauptverfasser: Yildiz, Elvin H, Hoskins, Eliza, Fram, Nicole, Rapuano, Christopher J, Hammersmith, Kristin M, Laibson, Peter R, Cohen, Elisabeth J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 259
container_issue 3
container_start_page 254
container_title Cornea
container_volume 29
creator Yildiz, Elvin H
Hoskins, Eliza
Fram, Nicole
Rapuano, Christopher J
Hammersmith, Kristin M
Laibson, Peter R
Cohen, Elisabeth J
description PURPOSE:The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP). METHODS:Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to identify all patients who had undergone three or more PKPs. Graft survival rates by initial diagnosis and risk factors for graft failure were analyzed. RESULTS:Forty-five patients who had three or more PKPs were identified. The total number of grafts identified in these 45 patients was 152, including 45 third PKPs, 11 fourth, three fifth, two sixth, and one seventh. The most common indication for the initial PKP was pseudophakic bullous keratopathy in 18 of 45 patients (41%) followed by Fuchs dystrophy (seven of 45 patients [16%]) and stromal dystrophies (five of 45 patients [11%]). Approximately half of third grafts (24 of 45 [53%]) and one fourth of fourth grafts (three of 11 [27%]) survived at the last follow-up visit with a median follow up of 4.3 years for the third grafts and 8.4 years for the fourth grafts. One-, 2-, and 5-year graft survival rates were 89%, 78%, and 53% for the third grafts and 73%, 73%, and 64% for the fourth grafts, respectively. The median survival time for the third graft was 12.8 years in Fuchs dystrophy, 5.2 years in herpetic keratitis, 4.0 years in keratoconus, 3.0 years in pseudophakic bullous keratopathy, 2.3 years in iridocorneal endothelial syndrome, and 2.0 years in stromal dystrophies. There is no statistically significant difference between groups (P = 0.46). Risk factor analysis on the third grafts showed that previous glaucoma procedures and corneal neovascularization are statistically significant risk factors for graft failure (P = 0.04 and 0.02, respectively). CONCLUSION:Over 50% of third and fourth grafts were clear at 5 years postoperatively. Outcomes of third grafts were better in patients with Fuchs dystrophy, keratoconus, and herpetic keratitis. Absence of previous glaucoma surgery and/or corneal neovascularization is associated with better outcomes of multiple PKPs.
doi_str_mv 10.1097/ICO.0b013e3181b31b6f
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733671584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733671584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421f-b7eb19dd52cc2eef22feb9e47b26515a4478ba120d8dd4a419389d8e61a851933</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78A5HcvGw1k6RN6k0WPxaFFfw6lqSZutVsuyat4r-3surBg6eZYZ53Bh5C9oEdAcvV8XQyO2KWgUABGqwAm1VrZASpyBKpcr1ORowrlQgl2RbZjvGZMaZUxjfJFmcAWmk5Io938zo42gZ6EdB0GOgNNtgF09XNE73CoWmX3sSuxnhCp42ry2HVNnFMb_vwVr8ZP6amcfShjr3xdNZ3ZbvAuEs2KuMj7n3XHXJ_fnY3uUyuZxfTyel1UkoOVWIVWsidS3lZcsSK8wptjlJZnqWQGimVtgY4c9o5aSTkQudOYwZGp8Mgdsjh6u4ytK89xq5Y1LFE702DbR8LJUSmINVyIOWKLEMbY8CqWIZ6YcJHAaz4MloMRou_RofYwfeD3i7Q_YZ-FA6AXgHvrR_8xRffv2Mo5mh8N___9ici2oWo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733671584</pqid></control><display><type>article</type><title>Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Yildiz, Elvin H ; Hoskins, Eliza ; Fram, Nicole ; Rapuano, Christopher J ; Hammersmith, Kristin M ; Laibson, Peter R ; Cohen, Elisabeth J</creator><creatorcontrib>Yildiz, Elvin H ; Hoskins, Eliza ; Fram, Nicole ; Rapuano, Christopher J ; Hammersmith, Kristin M ; Laibson, Peter R ; Cohen, Elisabeth J</creatorcontrib><description>PURPOSE:The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP). METHODS:Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to identify all patients who had undergone three or more PKPs. Graft survival rates by initial diagnosis and risk factors for graft failure were analyzed. RESULTS:Forty-five patients who had three or more PKPs were identified. The total number of grafts identified in these 45 patients was 152, including 45 third PKPs, 11 fourth, three fifth, two sixth, and one seventh. The most common indication for the initial PKP was pseudophakic bullous keratopathy in 18 of 45 patients (41%) followed by Fuchs dystrophy (seven of 45 patients [16%]) and stromal dystrophies (five of 45 patients [11%]). Approximately half of third grafts (24 of 45 [53%]) and one fourth of fourth grafts (three of 11 [27%]) survived at the last follow-up visit with a median follow up of 4.3 years for the third grafts and 8.4 years for the fourth grafts. One-, 2-, and 5-year graft survival rates were 89%, 78%, and 53% for the third grafts and 73%, 73%, and 64% for the fourth grafts, respectively. The median survival time for the third graft was 12.8 years in Fuchs dystrophy, 5.2 years in herpetic keratitis, 4.0 years in keratoconus, 3.0 years in pseudophakic bullous keratopathy, 2.3 years in iridocorneal endothelial syndrome, and 2.0 years in stromal dystrophies. There is no statistically significant difference between groups (P = 0.46). Risk factor analysis on the third grafts showed that previous glaucoma procedures and corneal neovascularization are statistically significant risk factors for graft failure (P = 0.04 and 0.02, respectively). CONCLUSION:Over 50% of third and fourth grafts were clear at 5 years postoperatively. Outcomes of third grafts were better in patients with Fuchs dystrophy, keratoconus, and herpetic keratitis. Absence of previous glaucoma surgery and/or corneal neovascularization is associated with better outcomes of multiple PKPs.</description><identifier>ISSN: 0277-3740</identifier><identifier>EISSN: 1536-4798</identifier><identifier>DOI: 10.1097/ICO.0b013e3181b31b6f</identifier><identifier>PMID: 20118784</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cornea - physiology ; Corneal Diseases - diagnosis ; Corneal Diseases - surgery ; Female ; Graft Rejection - diagnosis ; Graft Survival - physiology ; Humans ; Keratoplasty, Penetrating - statistics &amp; numerical data ; Male ; Middle Aged ; Reoperation ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Visual Acuity - physiology</subject><ispartof>Cornea, 2010-03, Vol.29 (3), p.254-259</ispartof><rights>Copyright © 2010 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421f-b7eb19dd52cc2eef22feb9e47b26515a4478ba120d8dd4a419389d8e61a851933</citedby><cites>FETCH-LOGICAL-c421f-b7eb19dd52cc2eef22feb9e47b26515a4478ba120d8dd4a419389d8e61a851933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20118784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yildiz, Elvin H</creatorcontrib><creatorcontrib>Hoskins, Eliza</creatorcontrib><creatorcontrib>Fram, Nicole</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Hammersmith, Kristin M</creatorcontrib><creatorcontrib>Laibson, Peter R</creatorcontrib><creatorcontrib>Cohen, Elisabeth J</creatorcontrib><title>Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes</title><title>Cornea</title><addtitle>Cornea</addtitle><description>PURPOSE:The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP). METHODS:Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to identify all patients who had undergone three or more PKPs. Graft survival rates by initial diagnosis and risk factors for graft failure were analyzed. RESULTS:Forty-five patients who had three or more PKPs were identified. The total number of grafts identified in these 45 patients was 152, including 45 third PKPs, 11 fourth, three fifth, two sixth, and one seventh. The most common indication for the initial PKP was pseudophakic bullous keratopathy in 18 of 45 patients (41%) followed by Fuchs dystrophy (seven of 45 patients [16%]) and stromal dystrophies (five of 45 patients [11%]). Approximately half of third grafts (24 of 45 [53%]) and one fourth of fourth grafts (three of 11 [27%]) survived at the last follow-up visit with a median follow up of 4.3 years for the third grafts and 8.4 years for the fourth grafts. One-, 2-, and 5-year graft survival rates were 89%, 78%, and 53% for the third grafts and 73%, 73%, and 64% for the fourth grafts, respectively. The median survival time for the third graft was 12.8 years in Fuchs dystrophy, 5.2 years in herpetic keratitis, 4.0 years in keratoconus, 3.0 years in pseudophakic bullous keratopathy, 2.3 years in iridocorneal endothelial syndrome, and 2.0 years in stromal dystrophies. There is no statistically significant difference between groups (P = 0.46). Risk factor analysis on the third grafts showed that previous glaucoma procedures and corneal neovascularization are statistically significant risk factors for graft failure (P = 0.04 and 0.02, respectively). CONCLUSION:Over 50% of third and fourth grafts were clear at 5 years postoperatively. Outcomes of third grafts were better in patients with Fuchs dystrophy, keratoconus, and herpetic keratitis. Absence of previous glaucoma surgery and/or corneal neovascularization is associated with better outcomes of multiple PKPs.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cornea - physiology</subject><subject>Corneal Diseases - diagnosis</subject><subject>Corneal Diseases - surgery</subject><subject>Female</subject><subject>Graft Rejection - diagnosis</subject><subject>Graft Survival - physiology</subject><subject>Humans</subject><subject>Keratoplasty, Penetrating - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Visual Acuity - physiology</subject><issn>0277-3740</issn><issn>1536-4798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMoun78A5HcvGw1k6RN6k0WPxaFFfw6lqSZutVsuyat4r-3surBg6eZYZ53Bh5C9oEdAcvV8XQyO2KWgUABGqwAm1VrZASpyBKpcr1ORowrlQgl2RbZjvGZMaZUxjfJFmcAWmk5Io938zo42gZ6EdB0GOgNNtgF09XNE73CoWmX3sSuxnhCp42ry2HVNnFMb_vwVr8ZP6amcfShjr3xdNZ3ZbvAuEs2KuMj7n3XHXJ_fnY3uUyuZxfTyel1UkoOVWIVWsidS3lZcsSK8wptjlJZnqWQGimVtgY4c9o5aSTkQudOYwZGp8Mgdsjh6u4ytK89xq5Y1LFE702DbR8LJUSmINVyIOWKLEMbY8CqWIZ6YcJHAaz4MloMRou_RofYwfeD3i7Q_YZ-FA6AXgHvrR_8xRffv2Mo5mh8N___9ici2oWo</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Yildiz, Elvin H</creator><creator>Hoskins, Eliza</creator><creator>Fram, Nicole</creator><creator>Rapuano, Christopher J</creator><creator>Hammersmith, Kristin M</creator><creator>Laibson, Peter R</creator><creator>Cohen, Elisabeth J</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201003</creationdate><title>Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes</title><author>Yildiz, Elvin H ; Hoskins, Eliza ; Fram, Nicole ; Rapuano, Christopher J ; Hammersmith, Kristin M ; Laibson, Peter R ; Cohen, Elisabeth J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421f-b7eb19dd52cc2eef22feb9e47b26515a4478ba120d8dd4a419389d8e61a851933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cornea - physiology</topic><topic>Corneal Diseases - diagnosis</topic><topic>Corneal Diseases - surgery</topic><topic>Female</topic><topic>Graft Rejection - diagnosis</topic><topic>Graft Survival - physiology</topic><topic>Humans</topic><topic>Keratoplasty, Penetrating - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yildiz, Elvin H</creatorcontrib><creatorcontrib>Hoskins, Eliza</creatorcontrib><creatorcontrib>Fram, Nicole</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Hammersmith, Kristin M</creatorcontrib><creatorcontrib>Laibson, Peter R</creatorcontrib><creatorcontrib>Cohen, Elisabeth J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cornea</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yildiz, Elvin H</au><au>Hoskins, Eliza</au><au>Fram, Nicole</au><au>Rapuano, Christopher J</au><au>Hammersmith, Kristin M</au><au>Laibson, Peter R</au><au>Cohen, Elisabeth J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes</atitle><jtitle>Cornea</jtitle><addtitle>Cornea</addtitle><date>2010-03</date><risdate>2010</risdate><volume>29</volume><issue>3</issue><spage>254</spage><epage>259</epage><pages>254-259</pages><issn>0277-3740</issn><eissn>1536-4798</eissn><abstract>PURPOSE:The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP). METHODS:Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to identify all patients who had undergone three or more PKPs. Graft survival rates by initial diagnosis and risk factors for graft failure were analyzed. RESULTS:Forty-five patients who had three or more PKPs were identified. The total number of grafts identified in these 45 patients was 152, including 45 third PKPs, 11 fourth, three fifth, two sixth, and one seventh. The most common indication for the initial PKP was pseudophakic bullous keratopathy in 18 of 45 patients (41%) followed by Fuchs dystrophy (seven of 45 patients [16%]) and stromal dystrophies (five of 45 patients [11%]). Approximately half of third grafts (24 of 45 [53%]) and one fourth of fourth grafts (three of 11 [27%]) survived at the last follow-up visit with a median follow up of 4.3 years for the third grafts and 8.4 years for the fourth grafts. One-, 2-, and 5-year graft survival rates were 89%, 78%, and 53% for the third grafts and 73%, 73%, and 64% for the fourth grafts, respectively. The median survival time for the third graft was 12.8 years in Fuchs dystrophy, 5.2 years in herpetic keratitis, 4.0 years in keratoconus, 3.0 years in pseudophakic bullous keratopathy, 2.3 years in iridocorneal endothelial syndrome, and 2.0 years in stromal dystrophies. There is no statistically significant difference between groups (P = 0.46). Risk factor analysis on the third grafts showed that previous glaucoma procedures and corneal neovascularization are statistically significant risk factors for graft failure (P = 0.04 and 0.02, respectively). CONCLUSION:Over 50% of third and fourth grafts were clear at 5 years postoperatively. Outcomes of third grafts were better in patients with Fuchs dystrophy, keratoconus, and herpetic keratitis. Absence of previous glaucoma surgery and/or corneal neovascularization is associated with better outcomes of multiple PKPs.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>20118784</pmid><doi>10.1097/ICO.0b013e3181b31b6f</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-3740
ispartof Cornea, 2010-03, Vol.29 (3), p.254-259
issn 0277-3740
1536-4798
language eng
recordid cdi_proquest_miscellaneous_733671584
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Aged, 80 and over
Cornea - physiology
Corneal Diseases - diagnosis
Corneal Diseases - surgery
Female
Graft Rejection - diagnosis
Graft Survival - physiology
Humans
Keratoplasty, Penetrating - statistics & numerical data
Male
Middle Aged
Reoperation
Retrospective Studies
Risk Factors
Treatment Outcome
Visual Acuity - physiology
title Third or Greater Penetrating Keratoplasties: Indications, Survival, and Visual Outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A44%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Third%20or%20Greater%20Penetrating%20Keratoplasties:%20Indications,%20Survival,%20and%20Visual%20Outcomes&rft.jtitle=Cornea&rft.au=Yildiz,%20Elvin%20H&rft.date=2010-03&rft.volume=29&rft.issue=3&rft.spage=254&rft.epage=259&rft.pages=254-259&rft.issn=0277-3740&rft.eissn=1536-4798&rft_id=info:doi/10.1097/ICO.0b013e3181b31b6f&rft_dat=%3Cproquest_cross%3E733671584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733671584&rft_id=info:pmid/20118784&rfr_iscdi=true